Genetic Associations With Toxicity-related Discontinuation of Aromatase Inhibitor Therapy for Breast Cancer

BACKGROUND: Up to 25% of patients discontinue adjuvant aromatase inhibitor (AI) therapy due to intolerable symptoms. Predictors of which patients will be unable to tolerate these medications have not been defined. We hypothesized that inherited variants in candidate genes are associated with treatme...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Henry, N. Lynn, Skaar, Todd C., Dantzer, Jessica, Li, Lang, Kidwell, Kelley, Gersch, Christina, Nguyen, Anne T., Rae, James M., Desta, Zeruesenay, Oesterreich, Steffi, Philips, Santosh, Carpenter, Janet S., Storniolo, Anna M., Stearns, Vered, Hayes, Daniel F., Flockhart, David A.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646626/
https://ncbi.nlm.nih.gov/pubmed/23546553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2504-3
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים